Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Real-world Experience of the Safety of Magnetic Resonance Imaging–guided Focused Ultrasound (MRgFUS)-thalamotomy for Essential Tremor
Movement Disorders
P3 - Poster Session 3 (5:30 PM-6:30 PM)
3-008

In a pivotal randomized clinical trial (RCT) in patients with essential tremor, MRgFUS-thalamotomy produced immediate and signi?cant tremor relief which has been sustained for at least 5 years. The procedure was generally well-tolerated and the most common adverse events (AEs) were transient and mild.

Assessment of the safety of MRgFUS-thalamotomy in patients with essential tremor in real-world clinical practice.

Safety findings from RCTs, in which strict patient-monitoring procedures are adhered to are not representative of everyday clinical practice. We therefore investigated safety findings from real-world sources including registries, the literature, company-reported complaints, and surveys data from commercial customers. These were compared with safety findings from the RCT of MRgFUS-thalamotomy in patients with essential tremor.

In the pivotal RCT, the most common AEs reported within 30 days of treatment were gait disturbance (18%) and paresthesias or numbness (25%). These persisted at 12 months in 9-14% of patients, respectively. After 5-years, all AEs were classi?ed as mild (71%) or moderate (29%) and none were serious. No new AEs related/probably-related to the procedure from the 12-month timepoint to the last follow-up at 5 years were observed. A similar safety profile was observed in a registry study which included 248 patients undergoing MRgFUS-thalamotomy, with no serious AEs recorded to date. Results from the literature were also very similar and included mild transitory procedure-related AEs (e.g., headache, nausea/vomiting, floating sensation) and short-term mild-to-moderate gait disturbances and paresthesias or numbness which diminished over time. AEs were reported in 2.6% of 3700 commercial procedures. Additional data from customer surveys (2018-2020) suggests that safety perception is good/fair to very good/excellent.

Overall, unilateral MRgFUS-thalamotomy in a real-world setting is safe and well-tolerated. This evidence supports the use of MRgFUS-thalamotony in patients with essential tremor in real-world, everyday clinical practice.

Authors/Disclosures
Neha Dhawan (Insightec)
PRESENTER
No disclosure on file
Gilat Schiff (Insightec) No disclosure on file
Amit Sokolov (Insightec) No disclosure on file
Giulia Frazzetta (Insightec) No disclosure on file
Katie Gant No disclosure on file